Atossa Therapeutics (ATOS)

Earnings in 2024 (TTM): -€23.66 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. . The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2024

Annual earnings

Year	Earnings	Change
2024	-€22.47 Million
2022	-€23.75 Million	30.84%
2021	-€18.16 Million	15.58%
2020	-€15.71 Million	3.41%
2019	-€15.19 Million	51.16%
2018	-€10.05 Million	40.41%
2017	-€7.16 Million	27.54%
2016	-€5.62 Million	-47.49%
2015	-€10.69 Million	-17.25%
2014	-€12.92 Million	35.91%
2013	-€9.51 Million	112.3%
2012	-€4.48 Million	46.53%
2011	-€3.06 Million

Earnings for similar companies or competitors

Company	Earnings	Earnings differencediff.	Country
Johnson & Johnson JNJ	€15.36 B	-68,489.27%	🇺🇸 USA
LabCorp LH	€1.02 B	-4,678.89%	🇺🇸 USA
Quest Diagnostics DGX	€1.03 B	-4,707.12%	🇺🇸 USA
Enzo Biochem ENZ	-€6.7 Million	-70.21%	🇺🇸 USA
Translate Bio TBIO.defunct	€36.71 M	-263.43%	🇺🇸 USA
NeoGenomics NEO	-€65.24 Million	190.38%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2024 (TTM): -€23.66 Million